Top 10 best children’s hospitals in the U.S.

Boston Children’s Hospital topped the charts as the best children’s hospital in the nation, according to a new ranking from U.S. News and World Report.

The rankings, now in their 16th year, recognize the top 50 medical centers ranked across 10 specialties, from pediatric cancer to pediatric cardiology, heart surgery and pediatric orthopedics. This year, 90 hospitals ranked in at least one top 10 list across specialties, while 10 made the Honor Roll list for being highly ranked across many specialties. 

The rankings are based on data collected from a clinical survey sent to nearly 200 hospitals and a survey sent to thousands of pediatric doctors nationwide. Both surveys were administered by RTI International, a North Carolina-based research and consulting firm.

Here are the top 10 children’s hospitals in the U.S.:

  1. Boston Children's Hospital
  2. Texas Children's Hospital, Houston
  3. Cincinnati Children's Hospital Medical Center
  4. Children's Hospital of Philadelphia
  5. Children's National Hospital, Washington, D.C
  6. UPMC Children's Hospital of Pittsburgh
  7. Children's Hospital Colorado, Aurora
  8. Children's Hospital Los Angeles
  9. Nationwide Children's Hospital, Columbus, Ohio
  10. Lucile Packard Children's Hospital Stanford, Palo Alto, California

Topping the list, Boston Children’s also was nationally ranked across 10 specialties.

 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.